• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

绘制比哈尔邦抗菌药物耐药性感染情况图:对加强政策和临床实践的启示

Mapping the AMR Infection Landscape in Bihar: Implications for Strengthening Policy and Clinical Practice.

作者信息

Modgil Vinay, Sahay Sundeep, Taneja Neelam, Qayyumi Burhanuddin, Singh Ravikant, Mukherjee Arunima, Bhoi Bibekananda, Arora Gitika

机构信息

Society for Health Information Systems Programmes (HISP India), New Delhi 110025, India.

Department of Informatics, University of Oslo, 0373 Oslo, Norway.

出版信息

Antibiotics (Basel). 2025 Jul 5;14(7):684. doi: 10.3390/antibiotics14070684.

DOI:10.3390/antibiotics14070684
PMID:40723987
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12291626/
Abstract

Antimicrobial resistance (AMR) poses a significant threat to public health, especially in low- and middle-income countries (LMICs), where surveillance infrastructure is underdeveloped. Bihar, India's third most populous state and one of its least-resourced states, has remained largely absent from national AMR monitoring initiatives. This study aimed to characterize the AMR infection landscape across five public tertiary care hospitals in Bihar over three years (2022-2024) and to assess the feasibility of integrating digital workflows for real-time microbiological reporting. Standardized antimicrobial susceptibility testing (AST) was performed on >48,000 urine, pus, and blood samples using CLSI guidelines. Facility-level data were digitized into an open-source AMR reporting system, enabling automated antibiogram generation. The findings revealed substantial resistance: high resistance to beta-lactams, carbapenems, and fluoroquinolones across pathogens. For instance, sensitivity to nitrofurantoin varied from 86.5% at NMCH (Patna) to 44.7% at JLNMCH (Bhagalpur), while cephalosporin sensitivity in spp. dropped below 2% in several hospitals. MRSA prevalence exceeded 65% in two facilities, far above the national average of 47.8%. Digital integration led to a four-fold increase in culture testing in all facilities and improved data completeness and turnaround times. Spatial analysis and microbiology laboratory assessment revealed significant geographic disparities in diagnostic access, with facilities in remote districts facing delays of over four hours for basic testing. Our study is the first study from India to create such a broad, facility-associated AMR picture over time at a state level. Policy implications include the need for a state-level AMR surveillance dashboard, alignment of procurement with facility-specific resistance patterns, and routine stewardship audits. Clinically, this study demonstrates the utility of localized antibiograms for guiding empirical therapy in resource-limited settings. This study provides a scalable framework for embedding AMR surveillance into routine health system workflows in LMICs.

摘要

抗菌药物耐药性(AMR)对公共卫生构成重大威胁,尤其是在低收入和中等收入国家(LMICs),这些国家的监测基础设施欠发达。比哈尔邦是印度人口第三多的邦,也是资源最匮乏的邦之一,在国家抗菌药物耐药性监测倡议中基本没有参与。本研究旨在描绘比哈尔邦五家公立三级护理医院在三年(2022 - 2024年)期间的抗菌药物耐药性感染情况,并评估整合数字工作流程以进行实时微生物报告的可行性。使用美国临床和实验室标准协会(CLSI)指南,对超过48000份尿液、脓液和血液样本进行了标准化抗菌药物敏感性测试(AST)。机构层面的数据被数字化录入一个开源抗菌药物耐药性报告系统,实现了自动抗菌谱生成。研究结果显示出大量耐药情况:多种病原体对β - 内酰胺类、碳青霉烯类和氟喹诺酮类药物耐药性高。例如,呋喃妥因的敏感性在那烂陀医学院医院(巴特那)为86.5%,在贾耶普拉卡什·纳拉扬医学院医院(巴格布尔)为44.7%,而在某些医院,肺炎克雷伯菌对头孢菌素的敏感性降至2%以下。在两家机构中,耐甲氧西林金黄色葡萄球菌(MRSA)的患病率超过65%,远高于全国平均水平47.8%。数字整合使所有机构的培养检测增加了四倍,并改善了数据完整性和周转时间。空间分析和微生物实验室评估显示,诊断服务在地理上存在显著差异,偏远地区的机构进行基本检测会延迟超过四个小时。我们的研究是印度首个在州一级随时间创建如此广泛且与机构相关的抗菌药物耐药性情况的研究。政策影响包括需要一个州级抗菌药物耐药性监测仪表板,使采购与机构特定的耐药模式保持一致,以及进行常规管理审计。在临床上,本研究证明了本地化抗菌谱在资源有限环境中指导经验性治疗的实用性。本研究为将抗菌药物耐药性监测嵌入低收入和中等收入国家常规卫生系统工作流程提供了一个可扩展的框架。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7a8/12291626/038bd987e79e/antibiotics-14-00684-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7a8/12291626/5ae4762303e7/antibiotics-14-00684-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7a8/12291626/d508181611cb/antibiotics-14-00684-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7a8/12291626/c55403e97e42/antibiotics-14-00684-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7a8/12291626/12818816d2d7/antibiotics-14-00684-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7a8/12291626/e420c5a0c1ce/antibiotics-14-00684-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7a8/12291626/f4c60f7a26d9/antibiotics-14-00684-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7a8/12291626/3db00529e8fb/antibiotics-14-00684-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7a8/12291626/d83e9dfbe725/antibiotics-14-00684-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7a8/12291626/bb2714dd029e/antibiotics-14-00684-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7a8/12291626/038bd987e79e/antibiotics-14-00684-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7a8/12291626/5ae4762303e7/antibiotics-14-00684-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7a8/12291626/d508181611cb/antibiotics-14-00684-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7a8/12291626/c55403e97e42/antibiotics-14-00684-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7a8/12291626/12818816d2d7/antibiotics-14-00684-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7a8/12291626/e420c5a0c1ce/antibiotics-14-00684-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7a8/12291626/f4c60f7a26d9/antibiotics-14-00684-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7a8/12291626/3db00529e8fb/antibiotics-14-00684-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7a8/12291626/d83e9dfbe725/antibiotics-14-00684-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7a8/12291626/bb2714dd029e/antibiotics-14-00684-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7a8/12291626/038bd987e79e/antibiotics-14-00684-g010.jpg

相似文献

1
Mapping the AMR Infection Landscape in Bihar: Implications for Strengthening Policy and Clinical Practice.绘制比哈尔邦抗菌药物耐药性感染情况图:对加强政策和临床实践的启示
Antibiotics (Basel). 2025 Jul 5;14(7):684. doi: 10.3390/antibiotics14070684.
2
The burden of bacterial antimicrobial resistance in the WHO African region in 2019: a cross-country systematic analysis.2019 年世卫组织非洲区域细菌对抗菌药物耐药性的负担:跨国系统分析。
Lancet Glob Health. 2024 Feb;12(2):e201-e216. doi: 10.1016/S2214-109X(23)00539-9. Epub 2023 Dec 19.
3
A baseline assessment of antimicrobial stewardship core element implementation in selected public hospitals in Malawi: findings from the 2023 National Program Audit.马拉维部分公立医院抗菌药物管理核心要素实施情况的基线评估:2023年国家项目审计结果
Front Public Health. 2025 Jun 12;13:1588778. doi: 10.3389/fpubh.2025.1588778. eCollection 2025.
4
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
5
Trends and patterns of antimicrobial resistance among common pathogens isolated from adult bloodstream and urinary tract infections in public health facilities in Malawi, 2020-2024.2020 - 2024年马拉维公共卫生机构中从成人血流和尿路感染分离出的常见病原体的抗菌药物耐药性趋势和模式
BMC Infect Dis. 2025 Jul 26;25(1):946. doi: 10.1186/s12879-025-11335-1.
6
Prevention and Treatment of Neonatal Infections in Facility and Community Settings of Low- and Middle-Income Countries: A Descriptive Review.低收入和中等收入国家医疗机构及社区环境中新生儿感染的预防与治疗:描述性综述
Neonatology. 2025;122(Suppl 1):173-208. doi: 10.1159/000541871. Epub 2024 Nov 12.
7
Rapid molecular tests for tuberculosis and tuberculosis drug resistance: a qualitative evidence synthesis of recipient and provider views.快速分子检测结核分枝杆菌和结核分枝杆菌耐药性:受检者和提供者观点的定性证据综合评价。
Cochrane Database Syst Rev. 2022 Apr 26;4(4):CD014877. doi: 10.1002/14651858.CD014877.pub2.
8
Performance of direct-from-blood-culture disk diffusion antibiotic susceptibility testing and its impact on antibiotic adjustment in bloodstream infections at a Malaysian tertiary center.马来西亚一家三级医疗中心直接从血培养进行纸片扩散法抗生素敏感性试验的性能及其对血流感染抗生素调整的影响。
Microbiol Spectr. 2025 Jun 18:e0286324. doi: 10.1128/spectrum.02863-24.
9
Influence of Sequencing Technology on Pangenome-level Analysis and Detection of Antimicrobial Resistance Genes in ESKAPE Pathogens.测序技术对泛基因组水平分析及ESKAPE病原体中抗菌药物耐药基因检测的影响
bioRxiv. 2025 Jan 10:2025.01.08.631980. doi: 10.1101/2025.01.08.631980.
10
Health professionals' experience of teamwork education in acute hospital settings: a systematic review of qualitative literature.医疗专业人员在急症医院环境中团队合作教育的经验:对定性文献的系统综述
JBI Database System Rev Implement Rep. 2016 Apr;14(4):96-137. doi: 10.11124/JBISRIR-2016-1843.

本文引用的文献

1
Tools and challenges in the use of routine clinical data for antimicrobial resistance surveillance.利用常规临床数据进行抗菌药物耐药性监测的工具与挑战。
NPJ Antimicrob Resist. 2025 May 9;3(1):37. doi: 10.1038/s44259-025-00105-3.
2
A systematic review and meta-analysis to develop a landscape map of antibiotic resistance for six WHO priority pathogens in east and north-east India from 2011 to 2022.一项系统综述和荟萃分析,旨在绘制2011年至2022年印度东部和东北部六种世界卫生组织重点病原体的抗生素耐药性图谱。
Indian J Med Microbiol. 2024 Nov-Dec;52:100732. doi: 10.1016/j.ijmmb.2024.100732. Epub 2024 Sep 25.
3
Global antimicrobial resistance and use surveillance system (GLASS 2022): Investigating the relationship between antimicrobial resistance and antimicrobial consumption data across the participating countries.
全球抗菌药物耐药性与使用监测系统(2022年):调查各参与国抗菌药物耐药性与抗菌药物消费数据之间的关系。
PLoS One. 2024 Feb 5;19(2):e0297921. doi: 10.1371/journal.pone.0297921. eCollection 2024.
4
Antibiotic susceptibility patterns of pathogens isolated from hospitalized patients with advanced HIV disease (AHD) in Bihar, India.印度比哈尔邦晚期艾滋病(AHD)住院患者分离出的病原体的抗生素敏感性模式。
JAC Antimicrob Resist. 2024 Jan 2;6(1):dlad151. doi: 10.1093/jacamr/dlad151. eCollection 2024 Feb.
5
Effective Stakeholder Engagement for Collation, Analysis and Expansion of Antimicrobial Resistance (AMR) Data: A CAPTURA Experience.有效利益相关者参与,以整理、分析和扩展抗生素耐药性 (AMR) 数据:CAPTURA 的经验。
Clin Infect Dis. 2023 Dec 20;77(Suppl 7):S519-S527. doi: 10.1093/cid/ciad585.
6
Response to antimicrobial resistance in South-East Asia Region.东南亚地区对抗菌素耐药性的应对措施。
Lancet Reg Health Southeast Asia. 2023 Oct 29;18:100306. doi: 10.1016/j.lansea.2023.100306. eCollection 2023 Nov.
7
High prevalence of ciprofloxacin resistance in Escherichia coli isolated from chickens, humans and the environment: An emerging one health issue.鸡、人和环境中分离的大肠杆菌对环丙沙星的高耐药率:一个新出现的同一健康问题。
PLoS One. 2023 Nov 20;18(11):e0294043. doi: 10.1371/journal.pone.0294043. eCollection 2023.
8
Has Data Quality of an Antimicrobial Resistance Surveillance System in a Province of Nepal Improved between 2019 and 2022?2019年至2022年间,尼泊尔某省抗菌药物耐药性监测系统的数据质量有所提高吗?
Trop Med Infect Dis. 2023 Aug 4;8(8):399. doi: 10.3390/tropicalmed8080399.
9
Antibiotic resistance, biofilm forming ability, and clonal profiling of clinical isolates of from southern and northeastern India.印度南部和东北部临床分离株的抗生素耐药性、生物膜形成能力及克隆分析。
Asian Biomed (Res Rev News). 2022 Aug 31;16(4):191-199. doi: 10.2478/abm-2022-0023. eCollection 2022 Aug.
10
Country data on AMR in India in the context of community-acquired respiratory tract infections: links between antibiotic susceptibility, local and international antibiotic prescribing guidelines, access to medicine and clinical outcome.关于社区获得性呼吸道感染中印度抗微生物药物耐药性的国家数据:抗生素药敏性、当地和国际抗生素使用指南、药物可及性和临床结果之间的联系。
J Antimicrob Chemother. 2022 Sep 6;77(Suppl_1):i10-i17. doi: 10.1093/jac/dkac212.